146 related articles for article (PubMed ID: 38470458)
1. Microfluidic Synthesis of CuH Nanoparticles for Antitumor Therapy through Hydrogen-Enhanced Apoptosis and Cuproptosis.
He G; Pan Y; Zeng F; Qin S; Luan X; Lu Q; Xie C; Hu P; Gao Y; Yang J; He B; Song Y
ACS Nano; 2024 Mar; 18(12):9031-9042. PubMed ID: 38470458
[TBL] [Abstract][Full Text] [Related]
2. An Enzyme-Engineered Nonporous Copper(I) Coordination Polymer Nanoplatform for Cuproptosis-Based Synergistic Cancer Therapy.
Xu Y; Liu SY; Zeng L; Ma H; Zhang Y; Yang H; Liu Y; Fang S; Zhao J; Xu Y; Ashby CR; He Y; Dai Z; Pan Y
Adv Mater; 2022 Oct; 34(43):e2204733. PubMed ID: 36054475
[TBL] [Abstract][Full Text] [Related]
3. Stimulus-Responsive Copper Complex Nanoparticles Induce Cuproptosis for Augmented Cancer Immunotherapy.
Hu F; Huang J; Bing T; Mou W; Li D; Zhang H; Chen Y; Jin Q; Yu Y; Yang Z
Adv Sci (Weinh); 2024 Apr; 11(13):e2309388. PubMed ID: 38269649
[TBL] [Abstract][Full Text] [Related]
4. A tumor microenvironment-responsive core-shell tecto dendrimer nanoplatform for magnetic resonance imaging-guided and cuproptosis-promoted chemo-chemodynamic therapy.
Ni C; Ouyang Z; Li G; Liu J; Cao X; Zheng L; Shi X; Guo R
Acta Biomater; 2023 Jul; 164():474-486. PubMed ID: 37040813
[TBL] [Abstract][Full Text] [Related]
5. Redox Homeostasis Disruptors Based on Metal-Phenolic Network Nanoparticles for Chemo/Chemodynamic Synergistic Tumor Therapy through Activating Apoptosis and Cuproptosis.
Zhao F; Yu H; Liang L; Wang C; Shi D; Zhang X; Ying Y; Cai W; Li W; Li J; Zheng J; Qiao L; Che S; Yu J
Adv Healthc Mater; 2023 Nov; 12(29):e2301346. PubMed ID: 37369362
[TBL] [Abstract][Full Text] [Related]
6. Tumor Microenvironment Responsive Hollow Nanoplatform for Triple Amplification of Oxidative Stress to Enhance Cuproptosis-Based Synergistic Cancer Therapy.
Xu W; Wang Y; Hou G; Wang J; Wang T; Qian J; Suo A
Adv Healthc Mater; 2023 May; 12(13):e2202949. PubMed ID: 36716523
[TBL] [Abstract][Full Text] [Related]
7. Elesclomol Loaded Copper Oxide Nanoplatform Triggers Cuproptosis to Enhance Antitumor Immunotherapy.
Lu X; Chen X; Lin C; Yi Y; Zhao S; Zhu B; Deng W; Wang X; Xie Z; Rao S; Ni Z; You T; Li L; Huang Y; Xue X; Yu Y; Sun W; Shen X
Adv Sci (Weinh); 2024 May; 11(18):e2309984. PubMed ID: 38430531
[TBL] [Abstract][Full Text] [Related]
8. DNAzyme-Mediated Cascade Nanoreactor for Cuproptosis-Promoted Pancreatic Cancer Synergistic Therapy.
Yu Q; Zhou J; Liu Y; Li XQ; Li S; Zhou H; Kang B; Chen HY; Xu JJ
Adv Healthc Mater; 2023 Nov; 12(28):e2301429. PubMed ID: 37548109
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial-Targeted Copper Delivery for Cuproptosis-Based Synergistic Cancer Therapy.
Deng J; Zhuang H; Shao S; Zeng X; Xue P; Bai T; Wang X; Shangguan S; Chen Y; Yan S; Huang W
Adv Healthc Mater; 2024 Mar; ():e2304522. PubMed ID: 38530073
[TBL] [Abstract][Full Text] [Related]
10. A Self-Amplifying ROS-Responsive Nanoplatform for Simultaneous Cuproptosis and Cancer Immunotherapy.
Wu H; Zhang Z; Cao Y; Hu Y; Li Y; Zhang L; Cao X; Wen H; Zhang Y; Lv H; Jin X
Adv Sci (Weinh); 2024 Jun; 11(23):e2401047. PubMed ID: 38569217
[TBL] [Abstract][Full Text] [Related]
11. Photoinduced Cuproptosis with Tumor-Specific for Metastasis-Inhibited Cancer Therapy.
Zheng J; Ge H; Guo M; Zhang T; Hu Q; Yao Q; Long S; Sun W; Fan J; Du J; Peng X
Small; 2024 Mar; 20(10):e2304407. PubMed ID: 37880907
[TBL] [Abstract][Full Text] [Related]
12. Cu
Ding H; Ren F; Liu P; Feng Y; Ma X; Shen Z; Shi Q; Xu M; Li W; Chen H
Angew Chem Int Ed Engl; 2023 Oct; 62(44):e202311549. PubMed ID: 37715322
[TBL] [Abstract][Full Text] [Related]
13. Coordination Self-Assembled AuTPyP-Cu Metal-Organic Framework Nanosheets with pH/Ultrasound Dual-Responsiveness for Synergistically Triggering Cuproptosis-Augmented Chemotherapy.
Bao J; Wang J; Chen S; Liu S; Wang Z; Zhang W; Zhao C; Sha Y; Yang X; Li Y; Zhong Y; Bai F
ACS Nano; 2024 Mar; 18(12):9100-9113. PubMed ID: 38478044
[TBL] [Abstract][Full Text] [Related]
14. Cuproptosis Induced by ROS Responsive Nanoparticles with Elesclomol and Copper Combined with αPD-L1 for Enhanced Cancer Immunotherapy.
Guo B; Yang F; Zhang L; Zhao Q; Wang W; Yin L; Chen D; Wang M; Han S; Xiao H; Xing N
Adv Mater; 2023 Jun; 35(22):e2212267. PubMed ID: 36916030
[TBL] [Abstract][Full Text] [Related]
15. In-situ fabrication of novel Au nanoclusters-Cu
Yang Z; Zhao Z; Cheng H; Shen Y; Xie A; Zhu M
J Colloid Interface Sci; 2023 Jul; 641():215-228. PubMed ID: 36933468
[TBL] [Abstract][Full Text] [Related]
16. A Stimulus-Responsive Ternary Heterojunction Boosting Oxidative Stress, Cuproptosis for Melanoma Therapy.
Huang Y; Chen C; Tan H; Dong S; Ren Y; Chao M; Yan H; Yan X; Jiang G; Gao F
Small; 2024 May; ():e2401147. PubMed ID: 38770990
[TBL] [Abstract][Full Text] [Related]
17. Syphilis mimetic nanoparticles for cuproptosis-based synergistic cancer therapy via reprogramming copper metabolism.
Zhang J; Han M; Zhang J; Abdalla M; Sun P; Yang Z; Zhang C; Liu Y; Chen C; Jiang X
Int J Pharm; 2023 Jun; 640():123025. PubMed ID: 37164186
[TBL] [Abstract][Full Text] [Related]
18. Copper Deposition in Polydopamine Nanostructure to Promote Cuproptosis by Catalytically Inhibiting Copper Exporters of Tumor Cells for Cancer Immunotherapy.
Chang J; Yin W; Zhi H; Chen S; Sun J; Zhao Y; Huang L; Xue L; Zhang X; Zhang T; Dong H; Li Y
Small; 2024 Feb; ():e2308565. PubMed ID: 38339770
[TBL] [Abstract][Full Text] [Related]
19. Biomimetic copper-doped polypyrrole nanoparticles induce glutamine metabolism inhibition to enhance breast cancer cuproptosis and immunotherapy.
Zhang N; Ping W; Rao K; Zhang Z; Huang R; Zhu D; Li G; Ning S
J Control Release; 2024 Jul; 371():204-215. PubMed ID: 38810704
[TBL] [Abstract][Full Text] [Related]
20. Cuproptosis: A novel therapeutic target for overcoming cancer drug resistance.
Wang Y; Chen Y; Zhang J; Yang Y; Fleishman JS; Wang Y; Wang J; Chen J; Li Y; Wang H
Drug Resist Updat; 2024 Jan; 72():101018. PubMed ID: 37979442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
